通过克服耐药性优化癌症治疗
Optimization Of Cancer Treatment Through Overcoming Drug Resistance.
作者信息
Elshimali Yahya I, Wu Yong, Khaddour Hussein, Wu Yanyuan, Gradinaru Daniela, Sukhija Hema, Chung Seyung S, Vadgama Jaydutt V
机构信息
Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, USA.
David Geffen School of Medicine at UCLA, UCLA's Jonsson Comprehensive Cancer Center, USA.
出版信息
J Cancer Res Oncobiol. 2018;1(2). doi: 10.31021/jcro.20181107. Epub 2018 Feb 27.
Abstract
Cancer Drug resistance is a medical concern that requires extensive research and a thorough understanding in order to overcome. Remarkable achievements related to this field have been accomplished and further work is needed in order to optimize the cure for cancer and serve as the basis for precise medicine with few or no side effects.
摘要
癌症耐药性是一个需要广泛研究和深入理解才能克服的医学问题。该领域已取得显著成就，但仍需要进一步开展工作，以优化癌症治疗方法，并为副作用少或无副作用的精准医学奠定基础。
相似文献
1
Optimization Of Cancer Treatment Through Overcoming Drug Resistance.通过克服耐药性优化癌症治疗
J Cancer Res Oncobiol. 2018;1(2). doi: 10.31021/jcro.20181107. Epub 2018 Feb 27.
2
Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.日本作为超老龄化社会的领跑者：来自日本医学与医疗护理的视角
Geriatr Gerontol Int. 2015 Jun;15(6):673-87. doi: 10.1111/ggi.12450. Epub 2015 Feb 5.
3
Resistance and Overcoming Resistance in Breast Cancer.乳腺癌中的耐药性与克服耐药性
Breast Cancer (Dove Med Press). 2020 Nov 11;12:211-229. doi: 10.2147/BCTT.S270799. eCollection 2020.
4
Current therapy and drug resistance in metastatic castration-resistant prostate cancer.转移性去势抵抗性前列腺癌的当前治疗与耐药性
Drug Resist Updat. 2023 May;68:100962. doi: 10.1016/j.drup.2023.100962. Epub 2023 Apr 14.
5
Advancements in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Breast Cancer Therapy.固体脂质纳米粒和纳米结构脂质载体在乳腺癌治疗中的进展。
Curr Pharm Des. 2024;30(37):2922-2936. doi: 10.2174/0113816128319233240725103706.
6
Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance.胰腺癌的纳米医学：克服治疗耐药性的现状与未来机遇
Cancers (Basel). 2021 Dec 7;13(24):6175. doi: 10.3390/cancers13246175.
7
Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.癌症治疗的靶向纳米医学：迈向克服耐药性的精准医学。
Drug Resist Updat. 2017 Mar;31:15-30. doi: 10.1016/j.drup.2017.05.002. Epub 2017 May 21.
8
Hybrid Drugs-A Strategy for Overcoming Anticancer Drug Resistance?杂交药物——克服抗癌药物耐药性的一种策略？
Molecules. 2021 Apr 29;26(9):2601. doi: 10.3390/molecules26092601.
9
Overcoming Cancer Resistance: Strategies and Modalities for Effective Treatment.克服癌症耐药性：有效治疗的策略与方式
Biomedicines. 2024 Aug 8;12(8):1801. doi: 10.3390/biomedicines12081801.
10
Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer.用于克服卵巢癌化疗耐药性的生物相容性聚集诱导发光剂/ P-糖蛋白小干扰RNA@还原敏感型紫杉醇聚合物前药纳米颗粒
Theranostics. 2021 Jan 27;11(8):3710-3724. doi: 10.7150/thno.53828. eCollection 2021.
引用本文的文献
1
Chromatin remodeling-driven autophagy activation induces cisplatin resistance in oral squamous cell carcinoma.染色质重塑驱动的自噬激活诱导口腔鳞状细胞癌对顺铂耐药。
Cell Death Dis. 2024 Aug 13;15(8):589. doi: 10.1038/s41419-024-06975-1.
2
Insights on the Role of Polyphenols in Combating Cancer Drug Resistance.多酚在对抗癌症耐药性中的作用见解
Biomedicines. 2023 Jun 14;11(6):1709. doi: 10.3390/biomedicines11061709.
3
Roles and regulatory mechanisms of KIN17 in cancers (Review).KIN17在癌症中的作用及调控机制（综述）
Oncol Lett. 2023 Feb 17;25(4):137. doi: 10.3892/ol.2023.13723. eCollection 2023 Apr.
4
Targeting Breast Cancer: An Overlook on Current Strategies.靶向乳腺癌：当前策略概述
Int J Mol Sci. 2023 Feb 11;24(4):3643. doi: 10.3390/ijms24043643.
5
The role of polyphenols in overcoming cancer drug resistance: a comprehensive review.多酚克服癌症药物耐药性的作用：全面综述。
Cell Mol Biol Lett. 2022 Jan 3;27(1):1. doi: 10.1186/s11658-021-00301-9.
6
Role of L1CAM in retinoblastoma tumorigenesis: identification of novel therapeutic targets.L1CAM 在视网膜母细胞瘤发生中的作用：新的治疗靶点的鉴定。
Mol Oncol. 2022 Feb;16(4):957-981. doi: 10.1002/1878-0261.13054. Epub 2021 Jul 18.
7
PLAC8 promotes adriamycin resistance via blocking autophagy in breast cancer.PLAC8 通过阻断乳腺癌中的自噬作用促进阿霉素耐药性。
J Cell Mol Med. 2021 Jul;25(14):6948-6962. doi: 10.1111/jcmm.16706. Epub 2021 Jun 11.
8
Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways.柑橘黄酮在癌症治疗中的作用：这种植物来源的天然化合物如何靶向多种致癌基因和抑癌基因途径。
Biomedicines. 2020 May 5;8(5):110. doi: 10.3390/biomedicines8050110.
9
Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents.川陈皮素及其衍生物克服癌症中的多药耐药性（MDR）：强效MDR逆转剂的全合成与发现
Acta Pharm Sin B. 2020 Feb;10(2):327-343. doi: 10.1016/j.apsb.2019.07.007. Epub 2019 Jul 31.
10
Cytotoxic and Antiproliferative Effects of Preussin, a Hydroxypyrrolidine Derivative from the Marine Sponge-Associated Fungus KUFA 0062, in a Panel of Breast Cancer Cell Lines and Using 2D and 3D Cultures.海洋海绵共生真菌 KUFA 0062 来源的羟吡咯烷衍生物 Preussin 对一组乳腺癌细胞系的细胞毒性和抗增殖作用及其在 2D 和 3D 培养中的应用。
Mar Drugs. 2019 Jul 30;17(8):448. doi: 10.3390/md17080448.
本文引用的文献
1
LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.长链非编码 RNA SNHG1 通过靶向 miR-15b-5p 激活 SIAH1 促进人神经母细胞瘤 SH-SY5Y 细胞中的 α-突触核蛋白聚集和毒性。
Neurotoxicology. 2018 Sep;68:212-221. doi: 10.1016/j.neuro.2017.12.001. Epub 2017 Dec 5.
2
PARP Inhibitors in Epithelial Ovarian Cancer.PARP抑制剂在上皮性卵巢癌中的应用
Recent Pat Anticancer Drug Discov. 2018;13(2):145-158. doi: 10.2174/1574892813666171204094822.
3
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition.耐药物持久性癌细胞易受谷胱甘肽过氧化物酶4（GPX4）抑制的影响。
Nature. 2017 Nov 9;551(7679):247-250. doi: 10.1038/nature24297. Epub 2017 Nov 1.
4
ABC-transporter blockage mediated by xanthotoxin and bergapten is the major pathway for chemosensitization of multidrug-resistant cancer cells.由花椒毒素和补骨脂素介导的ABC转运蛋白阻断是多药耐药癌细胞化学增敏的主要途径。
Toxicol Appl Pharmacol. 2017 Dec 15;337:22-29. doi: 10.1016/j.taap.2017.10.018. Epub 2017 Oct 25.
5
Betulinic acid induces apoptosis by regulating PI3K/Akt signaling and mitochondrial pathways in human cervical cancer cells.桦木酸通过调节人宫颈癌细胞中的PI3K/Akt信号通路和线粒体途径诱导细胞凋亡。
Int J Mol Med. 2017 Dec;40(6):1669-1678. doi: 10.3892/ijmm.2017.3163. Epub 2017 Sep 28.
6
Epithelial plasticity and cancer stem cells: Major mechanisms of cancer pathogenesis and therapy resistance.上皮可塑性与癌症干细胞：癌症发病机制及治疗耐药性的主要机制
World J Stem Cells. 2017 Aug 26;9(8):118-126. doi: 10.4252/wjsc.v9.i8.118.
7
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.用于癌症免疫治疗的PD-1和PD-L1检查点信号抑制：机制、联合应用及临床结果
Front Pharmacol. 2017 Aug 23;8:561. doi: 10.3389/fphar.2017.00561. eCollection 2017.
8
Emerging role of Hippo signalling pathway in bladder cancer.Hippo 信号通路在膀胱癌中的新兴作用。
J Cell Mol Med. 2018 Jan;22(1):4-15. doi: 10.1111/jcmm.13293. Epub 2017 Aug 7.
9
Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma Dissemination.多方面的C-X-C趋化因子受体4（CXCR4）抑制作用干扰抗血管内皮生长因子治疗诱导的胶质瘤播散。
Am J Pathol. 2017 Sep;187(9):2080-2094. doi: 10.1016/j.ajpath.2017.04.020. Epub 2017 Jul 20.
10
MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.微小RNA-125a-5p通过直接靶向信号转导和转录激活因子3（STAT3）在肺癌细胞中发挥肿瘤抑制作用。
Tumour Biol. 2017 Jun;39(6):1010428317697579. doi: 10.1177/1010428317697579.
Zotero 插件